enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Polysulfated glycosaminoglycan - Wikipedia

   en.wikipedia.org/wiki/Polysulfated_glycosaminoglycan

   Molar mass. 3,000–15,000 Da. Polysulfated glycosaminoglycan (PSGAG), sold under the brand name Adequan, is an injectable drug for dogs and horses that is used to alleviate the limpness, pain, and lowered range of motion caused by arthritis. [2] It is made of repeat disaccharide units (comprising hexosamine and hexuronic acid), and is similar ...

3. Grapiprant - Wikipedia

   en.wikipedia.org/wiki/Grapiprant

   Grapiprant. Grapiprant, sold under the brand name Galliprant, is a small molecule drug that belongs in the piprant class. This analgesic and anti-inflammatory drug is primarily used as a pain relief for mild to moderate inflammation related to osteoarthritis in dogs. Grapiprant has been approved by the FDA's Center for Veterinary Medicine and ...

4. Separation anxiety in dogs - Wikipedia

   en.wikipedia.org/wiki/Separation_anxiety_in_dogs

   Dogs suffering from separation anxiety are often "owner addicts." While treatment and management options are available for dogs suffering from separation anxiety, there is no instant cure. However, the disorder can dissipate on its own if the trigger stimulus is removed from its environment or the trigger stimulus is desensitized over a period.

5. Does My Dog Have Social Anxiety? - AOL

   www.aol.com/lifestyle/social-anxiety-dogs...

   Anxiety in dogs is similar to social anxiety in people. As such, it’s an extreme fear or stress related to social situations. Dog anxiety is normal for many dogs and can cause changes in ...

6. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   September 19, 2024 at 12:50 PM. (Reuters) -The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health regulator's website showed on ...

7. Maropitant - Wikipedia

   en.wikipedia.org/wiki/Maropitant

   Maropitant (INN; [2] brand name: Cerenia, used as maropitant citrate (USAN), is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [3][4] and in 2012, for cats. [5]